Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer

Authors:
  • JMJ.-J. Min
    J.-J. Min
  • JPJ.M. Park
    J.M. Park
  • JCJ.-K. Chung
    J.-K. Chung
  • BKB.T. Kim
    B.T. Kim
  • JJJ.M. Jeong
    J.M. Jeong
  • DLD.S. Lee
    D.S. Lee
  • MLM.C. Lee
    M.C. Lee
  • SHS.K. Han
    S.K. Han
  • YSY.S. Shim
    Y.S. Shim

Abstract
The aim of this study was to determine whether quantitative information obtained from [18F]fluorodeoxyglucose positron emission tomography (18F-FDG PET) has a prognostic significance for patients with non-small cell lung cancer (NSCLC). We investigated 18F-FDG PET imaging of 73 patients with NSCLC. The maximum standardized uptake value (SUVmax) was significantly different between the histopathological types of tumour (squamous cell carcinoma (n = 37, 12.4±5.1), adenocarcinoma (n = 30, 8.2±5.8), bronchioloalveolar carcinoma (n = 4, 2.6±1.7), P10) correlated exclusively with poorer survival (P = 0.031, relative risk = 11.152). 18F-FDG uptake correlated with survival in NSCLC. Especially in adenocarcinomas, the SUVmax was complementary to other known prognostic factors.

This publication has 12 references indexed in Scilit: